{"title":"Characterizing Navigational Changes in Preclinical Alzheimer’s Disease: A Route Complexity Metric Derived From Naturalistic Driving Data","authors":"Kelly Long;Ganesh M. Babulal;Sayeh Bayat","doi":"10.1109/JTEHM.2025.3619802","DOIUrl":null,"url":null,"abstract":"Objective: To examine how early pathophysiological changes in Alzheimer’s disease (AD) affect navigational decision-making by analyzing the complexity of driving routes in older adults with and without preclinical AD. Methods: We developed a novel route complexity metric based on the number of left and right turns and the deviation from the most direct path, accounting for cognitive load during navigation. Naturalistic GPS driving data were collected for a year from 111 older adults aged 65–85, with preclinical AD status determined via cerebrospinal fluid amyloid biomarkers. A multiple linear regression model was used to assess the relationship between age, preclinical AD status, and route complexity. Results: The findings of this study indicate that preclinical AD may influence the navigational abilities of older adults. After controlling for age, participants with preclinical AD chose routes with higher baseline complexity than the control group. It further revealed that participants with preclinical AD selected routes with lower complexity as they aged—a trend not observed in healthy controls. Conclusion: Preclinical AD is associated with changes in spatial decision-making that are observable in real-world driving behaviours. The age-related decline in route complexity among those with preclinical AD may reflect compensatory strategies or progressive cognitive changes. Clinical Impact: This study presents a non-invasive, behaviour-based metric that could support early detection of cognitive decline. It may also inform the design of personalized mobility interventions and dementia-friendly mobility systems.","PeriodicalId":54255,"journal":{"name":"IEEE Journal of Translational Engineering in Health and Medicine-Jtehm","volume":"13 ","pages":"471-479"},"PeriodicalIF":3.9000,"publicationDate":"2025-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ieeexplore.ieee.org/stamp/stamp.jsp?tp=&arnumber=11197551","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"IEEE Journal of Translational Engineering in Health and Medicine-Jtehm","FirstCategoryId":"5","ListUrlMain":"https://ieeexplore.ieee.org/document/11197551/","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: To examine how early pathophysiological changes in Alzheimer’s disease (AD) affect navigational decision-making by analyzing the complexity of driving routes in older adults with and without preclinical AD. Methods: We developed a novel route complexity metric based on the number of left and right turns and the deviation from the most direct path, accounting for cognitive load during navigation. Naturalistic GPS driving data were collected for a year from 111 older adults aged 65–85, with preclinical AD status determined via cerebrospinal fluid amyloid biomarkers. A multiple linear regression model was used to assess the relationship between age, preclinical AD status, and route complexity. Results: The findings of this study indicate that preclinical AD may influence the navigational abilities of older adults. After controlling for age, participants with preclinical AD chose routes with higher baseline complexity than the control group. It further revealed that participants with preclinical AD selected routes with lower complexity as they aged—a trend not observed in healthy controls. Conclusion: Preclinical AD is associated with changes in spatial decision-making that are observable in real-world driving behaviours. The age-related decline in route complexity among those with preclinical AD may reflect compensatory strategies or progressive cognitive changes. Clinical Impact: This study presents a non-invasive, behaviour-based metric that could support early detection of cognitive decline. It may also inform the design of personalized mobility interventions and dementia-friendly mobility systems.
期刊介绍:
The IEEE Journal of Translational Engineering in Health and Medicine is an open access product that bridges the engineering and clinical worlds, focusing on detailed descriptions of advanced technical solutions to a clinical need along with clinical results and healthcare relevance. The journal provides a platform for state-of-the-art technology directions in the interdisciplinary field of biomedical engineering, embracing engineering, life sciences and medicine. A unique aspect of the journal is its ability to foster a collaboration between physicians and engineers for presenting broad and compelling real world technological and engineering solutions that can be implemented in the interest of improving quality of patient care and treatment outcomes, thereby reducing costs and improving efficiency. The journal provides an active forum for clinical research and relevant state-of the-art technology for members of all the IEEE societies that have an interest in biomedical engineering as well as reaching out directly to physicians and the medical community through the American Medical Association (AMA) and other clinical societies. The scope of the journal includes, but is not limited, to topics on: Medical devices, healthcare delivery systems, global healthcare initiatives, and ICT based services; Technological relevance to healthcare cost reduction; Technology affecting healthcare management, decision-making, and policy; Advanced technical work that is applied to solving specific clinical needs.